Your browser doesn't support javascript.
loading
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Avivi, Irit; Perry, Chava; Segman, Yafit; Amit, Odelia; Bar-On, Yaeli; Katz, Ofrat Beyer; Gold, Ronit; Ribakovsky, Elena; Avigdor, Abraham; Vainstein, Vladimir; Goldschmidt, Neta; Ringelstein-Harlev, Shimrit; Horowitz, Netanel A; Gutwein, Odit; Gurion, Ronit; Itchaki, Gilad; Abadi, Uri; Nemets, Anatoly; Sofer, Orit; Vezker, Miri; Tadmor, Tamar; Dally, Najib; Filanovsky, Kalman; Leiba, Merav; Sarid, Nadav; Benyamini, Noam; Luttwak, Efrat; Herishanu, Yair; Ram, Ron.
Afiliación
  • Avivi I; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Perry C; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Segman Y; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Amit O; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Bar-On Y; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Katz OB; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Gold R; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ribakovsky E; Hematology Division, Chaim Sheba Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel.
  • Avigdor A; Hematology Division, Chaim Sheba Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel.
  • Vainstein V; Hematology Division, Hadassah Medical Center and the Hebrew Faculty of Medicine, Jerusalem University, Jerusalem, Israel.
  • Goldschmidt N; Hematology Division, Hadassah Medical Center and the Hebrew Faculty of Medicine, Jerusalem University, Jerusalem, Israel.
  • Ringelstein-Harlev S; Department of Hematology, Rambam Healthcare Campus, Haifa, Israel.
  • Horowitz NA; Department of Hematology, Rambam Healthcare Campus, Haifa, Israel.
  • Gutwein O; Department of Hematology, Assaf Harofeh Medical Center, Tzrifin, Israel.
  • Gurion R; Institute of Hematology, Rabin Medical Center, Petch Tikva, Israel.
  • Itchaki G; Institute of Hematology, Rabin Medical Center, Petch Tikva, Israel.
  • Abadi U; Department of Hematology, Meir Medical Center, Kfar Saba, Israel.
  • Nemets A; Department of Hematology, Barzilai Medical Center, Ashkelon, Israel.
  • Sofer O; Institute of Hematology, Hillel Yaffe Medical Center, Hadera, Israel.
  • Vezker M; Department of Hematology, Soroka University Medical Center, Negev, Beer Sheva, Israel.
  • Tadmor T; Hematology Unit, Bnai-Zion Medical Center, Haifa, Israel.
  • Dally N; Hematology Unit, Ziv Medical Center, Zefat, Israel.
  • Filanovsky K; Hematology Unit, Kaplan Medical Center, Rehovot, Israel.
  • Leiba M; Hematology Institute, Assuta Medical Center, Ashdod, Israel.
  • Sarid N; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Benyamini N; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Luttwak E; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Herishanu Y; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ram R; Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ronram73@gmail.com.
Ann Hematol ; 101(4): 755-762, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35083525

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Inmunoconjugados / Receptores Quiméricos de Antígenos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Inmunoconjugados / Receptores Quiméricos de Antígenos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Alemania